| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 5.69M | — |
| Operating expense | — | — |
| Net income | -5.18M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CUE returned -6.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +152.7% |
| 1 year | -6.7% |
| 5 years | -93.6% |
| All-time high | $830.40 (May 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CUE would be worth today ›No. Cue Biopharma, Inc. has not paid a dividend in the past 12 months.
Cue Biopharma, Inc. stock trades on NASDAQ under the ticker symbol CUE.
Cue Biopharma, Inc. is part of the Healthcare sector.
Cue Biopharma, Inc. has a market cap of 167.95M USD, based on the latest quote.
